Insider Cluster (3 insiders) ·Filed Sep 9, 2026

TARS

Tarsus Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed22d 8h ago
Insider cluster: 3 insiders, $1.3M total
Actionable Insight • Neutral

The selling is routine in size and involves multiple C-suite executives, but the lack of any insider buying and the concentration of sales near the $85-91 range warrants monitoring for any upcoming corporate events or earnings. No immediate action needed.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
TARS ▼ -6.20% at T+5d
NEUTRAL call ✗ call lost -6.20% · α vs SPY -5.54% · entry $82.77 → $77.64
Next anchor: T+20d in 4d
Latest observation: T+13 -10.24% FF3 residual α
Entry anchored
Sep 8, 07:29 PM ET
via 1-min bar
T+1d
-1.99%
call -1.99% · α -1.39%
$81.12
settled 23d ago
T+5d
-6.20%
call -6.20% · α -5.54%
$77.64
settled 17d ago
T+20d
—
call — · α —
—
in 4d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Three top insiders (CEO, COO, CMO) sold shares totaling ~$2.5M over a one-week window ending September 4, 2026. The total represents less than 0.1% of TARS's $3.8B market cap, making this a routine cluster of insider sales with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$2.5M
Insiders
3

Key Facts

  • CEO Bobak Azamian sold ~$906K worth of shares across two transactions on Sep 2 and Sep 4.
  • CMO Elizabeth Yeu sold ~$1.24M across five transactions on Sep 4.
  • COO Seshadri Neervannan sold ~$388K on Sep 4.
  • Total insider sales in the cluster: ~$2.5M, or ~0.066% of market cap.
  • No open-market purchases were reported in the cluster.

Financial Impact

Insider selling of ~$2.5M is immaterial relative to $3.8B market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TARS-1789030949522
13 reports for TARS
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +27.36%Aug 6, 2026
Filters
Rows
Reports for TARS — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$82.77 $77.64▼ −6.20%▼ −5.54%$73.61 (−11.06%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$83.21 $79.31▼ −4.68%▼ −3.53%$73.61 (−11.53%)
Sep 2, 2026
29d ago
144
BEARISH ★ 4/10
$82.76 $81.12▲ +1.98%▲ +1.02%$73.61 (+11.05%)
Sep 1, 2026
4w ago
144
BEARISH ★ 5/10
$82.76 $81.12▲ +1.98%▲ +1.02%$73.61 (+11.05%)
Aug 19, 2026
6w ago
144
NEUTRAL ★ 3/10
$73.44 $70.65▼ −3.80%▼ −3.41%$73.61 (+0.24%)
Aug 6, 2026
8w ago
8-K
MIXED ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
8-K
MIXED ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Aug 6, 2026
8w ago
Press Release
BULLISH ★ 6/10
$65.33 $68.88▲ +5.43%▲ +4.22%$73.61 (+12.68%)
Showing 10 of 13

US Market Status

Market Open — Closes in 2h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 10, 2026